Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
Orca Biosystems, Inc.
Corcept Therapeutics
Boston Scientific Corporation
AstraZeneca
AstraZeneca
Revolution Medicines, Inc.
NiKang Therapeutics, Inc.
Genelux Corporation
Cogent Biosciences, Inc.
Promontory Therapeutics Inc.
Hoffmann-La Roche
Daiichi Sankyo
Sinocelltech Ltd.
Dendreon
Novartis
Merck KGaA, Darmstadt, Germany
SciClone Pharmaceuticals
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Eli Lilly and Company